How Many SARS-CoV-2–Infected People Require Hospitalization? Using Random Sample Testing to Better Inform Preparedness Efforts
نویسندگان
چکیده
Context: Existing hospitalization ratios for COVID-19 typically use case counts in the denominator, which problematically underestimates total infections because asymptomatic and mildly infected persons rarely get tested. As a result, surge models that rely on to forecast hospital demand may be inaccurately influencing policy decision-maker action. Objective: Based SARS-CoV-2 prevalence data derived from statewide random sample (as opposed relying reported counts), we determine infection-hospitalization ratio (IHR), defined as percentage of individuals who are hospitalized, various demographic groups Indiana. Furthermore, comparison, show extent case-based ratios, compared with IHR, overestimate probability by group. Design: Secondary analysis Indiana, extracted health information exchange, all cases state department. Setting: State Indiana April 30, 2020. Main Outcome Measure(s): Demographic-stratified IHRs case-hospitalization ratios. Results: The overall IHR was 2.1% varied more age than race or sex. Infection-hospitalization estimates ranged 0.4% those younger 40 years 9.2% older 60 years. Hospitalization rates based overestimated factor 10, but this overestimation differed groups, especially age. Conclusions: In first study population prevalence, our results can improve forecasting demand—especially preparation upcoming winter period when an increase SARS CoV-2 is expected.
منابع مشابه
Serology Testing for SARS-CoV-2: Benefits and Challenges
As COVID-19 was declared as a pandemic by the World Health Organization (WHO) in March 2020, it is an emerging need to discuss different aspects of this pandemic. In any pandemic, valid and rapid laboratory diagnostic tests are critically important for early diagnosis, which will increase the rate of successful treatment and more importantly prevent the spread of the disease.
متن کاملHospital Preparedness and SARS
On May 23, 2003, Toronto experienced the second phase of a severe acute respiratory syndrome (SARS) outbreak. Ninety cases were confirmed, and >620 potential cases were managed. More than 9,000 persons had contact with confirmed or potential case-patients; many required quarantine. The main hospital involved during the second outbreak was North York General Hospital. We review this hospital's r...
متن کاملSARS-CoV-2 and its dynamic impact on emergency department preparedness and management
Introduction: Emerging viral diseases (EVDs) pose a significant threat to public health. There have been a few viral epidemics in the last two decades. Coronavirus disease 2019 (COVID-19) is now a global pandemic.Objective: To provide emergency physicians an update on severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and its dynamic impact on the emergency department (ED) in te...
متن کاملWhole-inactivated SARS-CoV-2 vaccines: from fear to hope
Undoubtedly, vaccination can be one of the promising approaches to control infectious diseases such as the COVID-19 pandemic. Inactivated viral vaccines have a history of "vaccine-induced enhanced disease", which may occur when neutralizing antibodies bind to viral antigens without blocking or clearing the infection. This can cause additional inflammation through the mechanisms described for ot...
متن کاملSARS Preparedness and Response Planning
On July 5, 2003, less than 4 months after the first cases of severe acute respiratory syndrome (SARS) were recognized, the World Health Organization (WHO) declared that the global epidemic had been contained. Although the United States was not as severely affected by the SARS epidemic as parts of Asia and Canada, the outbreak response demonstrated both known and unexpected strengths and weaknes...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Journal of Public Health Management and Practice
سال: 2021
ISSN: ['1550-5022', '1078-4659']
DOI: https://doi.org/10.1097/phh.0000000000001331